Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PREMPLUS 0.625 MG — DIN 02242878

CONJUGATED ESTROGENS : 0.625 MG MEDROXYPROGESTERONE ACETATE : 2.5 MG · PFIZER CANADA ULC · TABLET ; KIT · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is PREMPLUS?

PREMPLUS 0.625 MG contains CONJUGATED ESTROGENS : 0.625 MG MEDROXYPROGESTERONE ACETATE : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02242878, held by PFIZER CANADA ULC, supplied as TABLET ; KIT for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 06-Nov-2019. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

How much does Medroxyprogesterone And Estrogen cost around the world?

Medroxyprogesterone And Estrogen is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Morocco publishes a PPV (public price); South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition431USD███.██
Australiaex-manufacturer319AUD███.██
South Africasingle exit price78ZAR███.██
MoroccoPPV (public price)11MAD███.██

59 pack listings across 15 brand entries and 4 price bases, refreshed 08 Sep 2026. Ranges span every Medroxyprogesterone And Estrogen pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.

Is there a generic Medroxyprogesterone And Estrogen in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

Only one market authorization holder has a Canadian DIN containing Medroxyprogesterone And Estrogen — 3 DINs, of which 0 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.

Market authorization holderDINsMarketedBrand namesPosition
PFIZER CANADA ULC30PREMPLUS, PREMPLUS CYCLENo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label0.625 MG
Dosage formTABLET ; KIT
RouteORAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceMedroxyprogesterone And Estrogen
ATC codeG03FA12
AHFS class28:24.92
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02242878
DIN (unpadded, as printed on some documents)2242878
Brand namePREMPLUS
Generic / active ingredientCONJUGATED ESTROGENS : 0.625 MG MEDROXYPROGESTERONE ACETATE : 2.5 MG
Market authorization holderPFIZER CANADA ULC
Health Canada schedulePrescription
ATC codeG03FA12
ATC anatomical main groupG — Genito-urinary system and sex hormones
ATC therapeutic subgroupG03FA
Current statusCANCELLED POST MARKET
Status date06-Nov-2019
Original market date2001-04-05 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
PREMPLUS5 MGKIT ; TABLETPFIZER CANADA ULCCANCELLED POST MARKET02242879
PREMPLUS CYCLE10 MGKIT ; TABLETPFIZER CANADA ULCCANCELLED PRE MARKET02242880

2 · Same class — other molecules in ATC G03FA

MoleculeCanadian brandsDINsMarketedSourceable
Norethisterone And EstrogenACTIVELLE · ACTIVELLE LD · ESTALIS 140/50 MCG · ESTALIS 250/50 MCG · +1 more54Yes
Progesterone And EstrogenACH-PROGESTERONE · BIJUVA · ESTROGEL PROPAK · M-PROGESTERONE53Yes
Drospirenone And EstrogenANGELIQ11Yes
Medroxyprogesterone And EstrogenPREMPLUS · PREMPLUS CYCLE30Not in Canada
Levonorgestrel And EstrogenCLIMARA PRO10Not in Canada
Norgestimate And EstrogenPREFESTA10Not in Canada
Ethisterone And EstrogenNEO MENS TAB10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC G03F

ATC subgroupMoleculesDINsMarketed
G03FBNorethisterone And Estrogen30

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is PREMPLUS called?

The same molecule, Medroxyprogesterone And Estrogen, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
ProveraLatinAustralia
RaloveraLatinAustralia
Depo-ProveraLatinAustralia
FARLUTALLatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02242878. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.